Strategic Pharma and Biotech Consultants with Diverse, Real-World Experience
ABOUT ARCHBOW
Archbow is a strategic consulting practice for the pharma & biotech industry.
Our company was founded by industry veterans to meet a need in the marketplace for consulting options that offer diverse, real-world experience, are able to leverage deep connections across the industry, and can also provide actionable strategic guidance.
Archbow approaches every project as a unique partnership, looking beyond the traditional suite of services to deliver enduring solutions at every stage of your product’s lifecycle.
We know what it takes to propel brands to success.
SERVICES
Distribution Support
Market Intelligence
International Solutions
Patient Support
Payer Strategy
Project Management
TEAM
Thanks again for the great work here. I enjoyed working with you and the team. The work was high quality, and I’m sure our paths will continue to cross down the line.
— Senior Director at a Top 10 pharmaceutical company
CASE STUDIES
BLOG
January 13, 2020
Q&A on how traditional pharmaceutical distribution must be transformed to meet the challenges of revolutionary Cell and Gene Therapies.
January 7, 2020
Pharmaceutical Executive worked with Archbow’s distribution experts, Kevin Cast, Rob Besse, and Paul Furgal, to find out which trends we should be watching as we welcome 2020.
November 19, 2019
A well-organized Ad Board can provide a pharmaceutical manufacturer with numerous advantages over traditional, structured market-research. These 5 essentials will help your next Ad Board be a success.
November 5, 2019
In a Q&A, Rob Besse shares his thoughts on making the leap from his family’s business to consulting, what manufacturers need to know before commercialization planning, and industry trends worth watching.
October 28, 2019
When manufacturers are planning the launch of a Buy-and-Bill product, there are certain steps that are imperative to include in the launch strategy and development of support services.
October 21, 2019
Determining if your HUB should be insourced, outsourced, or a hybrid of those two options is a big decision. And finding the right answer can determine the future success of your patient access program.
September 19, 2019
Before establishing an Expanded Access Program, it’s vital for manufacturers to align internally around several crucial program decisions. These five are key.
August 26, 2019
With no roadmap for Cell and Gene Therapy, it can be overwhelming to try to stay on top of all the moving parts. This overview of 4 key CGT topics will keep you up to date.
August 12, 2019
In addition to saving time and money, investing in project management can provide competitive advantage. If your organization can deliver strategic projects quicker and more efficiently, and fewer projects fail, it positively impacts the bottom line. Includes 5 ways to...
July 30, 2019
Key takeaways from 2019 World Congress Integrate meeting. Six essentials for improving support and access from manufacturers to patients, providers, and networks. IDNs, SP contracts, 501c3 compliance, VBCs, and more.
CONTACT US
Let us know about your business, your goals, your challenges. We're experts at mapping out your path to success. Fill in the form below, email us, or give us a call. We'd love to hear from you.
U.S. office
4700 Millenia Blvd.
Suite 175
Orlando, FL 32839
(321) 355-2686
Europe office
Dammstrasse 19
6300 Zug
Switzerland
+ 41 (0)41 723 23 70
